Evidence map›Paper›PMID 42203812›Full record

ArticleScientific reports2026

Modeling engineering and medical lifetime data using a flexible extension of the XShanker distribution under censoring.

Amal S Hassan, Ghadah Alomani, Amer Ibrahim Al-Omari, Maisaa M Hassan

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Amal S HassanFaculty of Graduate Studies for Statistical Research, Cairo University, 5 Dr. Ahmed Zewail Street, Giza, 12613, Egypt.ORCID http://orcid.org/0000-0003-4442-8458
Ghadah AlomaniDepartment of Mathematical Sciences, College of Science, Princess Nourah Bint Abdulrahman University, P.O. Box 84428, 11671, Riyadh, Saudi Arabia.
Amer Ibrahim Al-OmariDepartment of Mathematics, Faculty of Science, Al Al-Bayt University, Mafraq, 25113, Jordan. alomari_amer@yahoo.com.
Maisaa M HassanModern Academy for Computer Science and Management Technology, Cairo, Egypt.ORCID http://orcid.org/0009-0006-1973-3978

Funding

Princess Nourah Bint Abdulrahman University PNURSP2026R226
6 · The paper itself

Abstract

The complexity of today's lifetime data necessitates more adaptable probability models. To address this need, we develop the Cosine Topp-Leone XShanker Distribution (CTL-XSD), a novel two-parameter extension of the XShanker distribution. We provide the mathematical properties of the new model, including its moments, incomplete moments, identifiability, quantiles, Lorenz curve, and Bonferroni curve. Using Type-II censoring, we employ both classical and Bayesian methods to estimate the parameters, survival function, and hazard function. Using Markov Chain Monte Carlo techniques, we derive Bayesian point and credible interval estimates under both symmetric and asymmetric loss functions. Additionally, we obtain the asymptotic confidence intervals based on the Fisher information matrix. We also provide a numerical study to evaluate the performance of the various estimators. We compare our findings with those from other models in the context of lifetime data analysis. The CTL-XSD outperformed the alternative models in terms of the Kolmogorov-Smirnov test statistic, with values of 0.98886 and 0.98438 in the context of engineering and medical datasets, respectively, with the lowest values in terms of all information criteria.

Indexed as

Approximate confidence intervalsBayesian estimationCosine Topp-Leone–GIdentifiabilityMetropolis–Hastings algorithmMinimum expected loss function

Identifiers

PMID42203812
PMCPMC13447818

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.